AMPA receptor blockade potentiates the stimulatory effect of L-DOPA on dopamine release in dopamine-deficient corticostriatal slice preparation.
@article{Jurnyi2004AMPARB, title={AMPA receptor blockade potentiates the stimulatory effect of L-DOPA on dopamine release in dopamine-deficient corticostriatal slice preparation.}, author={Z. Jur{\'a}nyi and N. Sziray and B. Mark{\'o} and G. L{\'e}vay and L. H{\'a}rsing}, journal={Critical reviews in neurobiology}, year={2004}, volume={16 1-2}, pages={ 129-39 } }
The release of [3H]dopamine was measured in rat corticostriatal slice preparations that contained the striatum and the adjacent prefrontal cortex to maintained glutamatergic corticostriatal afferentation. These slices were prepared from either nontreated or 6-hydroxydopamine-pretreated rats. The slices were loaded with [3H]dopamine, submerged in a two-compartment bath so that the cortical region was contained in one compartment, the corpus callosum was passed through a silicone greased slot… Expand
Topics from this paper
12 Citations
Effects of 2,3-benzodiazepine AMPA receptor antagonists on dopamine turnover in the striatum of rats with experimental parkinsonism
- Medicine
- Brain Research Bulletin
- 2007
- 9
Combined blockade of AMPA and NMDA glutamate receptors reduces levodopa-induced motor complications in animal models of PD
- Medicine
- Experimental Neurology
- 2005
- 121
The effect of antiparkinsonian drugs on oxidative stress induced pathological [3H]dopamine efflux after in vitro rotenone exposure in rat striatal slices
- Chemistry, Medicine
- Neuropharmacology
- 2010
- 17
- PDF
Investigation of the antidyskinetic site of action of metabotropic and ionotropic glutamate receptor antagonists. Intracerebral infusions in 6-hydroxydopamine-lesioned rats with levodopa-induced dyskinesia.
- Chemistry, Medicine
- European journal of pharmacology
- 2012
- 16
Metabotropic Glutamate Receptors for Parkinson's Disease Therapy
- Medicine
- Parkinson's disease
- 2013
- 46
- PDF
2,3-Benzodiazepine-type AMPA receptor antagonists and their neuroprotective effects
- Biology, Medicine
- Neurochemistry International
- 2008
- 30
Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease
- Psychology, Medicine
- Progress in Neurobiology
- 2015
- 262
Influence of the N-acetylation polymorphism on the metabolism of talampanel: an investigation in fasted and fed subjects genotyped for NAT2 variants.
- Chemistry, Medicine
- Die Pharmazie
- 2006
- 3
Levodopa, motor fluctuations and dyskinesia in Parkinson’s disease
- Medicine
- Expert opinion on pharmacotherapy
- 2006
- 62